Keyphrases
Concurrent Use
100%
Antioxidant System
100%
Antioxidant Supplementation
100%
Cell-free DNA (cfDNA)
100%
Chemotherapy
100%
Cancer Patients
100%
Prostate Cancer
100%
Oxidative Stress
100%
Omani
100%
Response Assessment
75%
Cancer Incidence
50%
Tumor Marker
50%
Diagnostic Tool
50%
Oman
50%
Prostate Cancer Patients
25%
Treatment Options
25%
Robust Diagnostics
25%
Diagnostic Assessment
25%
Relevant Genes
25%
Next-generation Sequencing
25%
Causes of Mortality
25%
Stage at Diagnosis
25%
Exome Sequencing
25%
Ion Proton
25%
Healthcare System
25%
SNP
25%
Developing Countries
25%
Omani Patients
25%
Medicine and Dentistry
Chemotherapy
100%
Antioxidant
100%
Prostate Cancer
100%
Patient
100%
Oxidative Stress
100%
Malignant Neoplasm
100%
Cell-Free DNA
80%
Diagnosis
60%
Assessment
60%
Cancer Incidence
40%
Tumor Marker
40%
Next Generation Sequencing
40%
Diagnostic Procedure
20%
Circulation
20%
Single Nucleotide Polymorphism
20%
Sensitivity and Specificity
20%
Proton
20%
Health Care
20%
Screening
20%
Mortality
20%
Exome Sequencing
20%
Diagnostic Procedure
20%
Man
20%
Therapeutic Procedure
20%
Gene
20%
INIS
chemotherapy
100%
antioxidants
100%
patients
100%
cancer
100%
oxidation
100%
prostate
52%
dna
42%
assessments
31%
oman
21%
diagnostic techniques
21%
tumors
21%
men
10%
specificity
10%
ions
10%
genes
10%
levels
10%
protons
10%
tools
10%
screening
10%
panels
10%
mortality
10%
data
10%
sensitivity
10%
developing countries
10%